160 related articles for article (PubMed ID: 19880564)
61. Interferon regulatory factors: critical mediators of human lupus.
Jensen MA; Niewold TB
Transl Res; 2015 Feb; 165(2):283-95. PubMed ID: 25445206
[TBL] [Abstract][Full Text] [Related]
62. The innate immune system in human systemic lupus erythematosus.
Weidenbusch M; Kulkarni OP; Anders HJ
Clin Sci (Lond); 2017 Apr; 131(8):625-634. PubMed ID: 28351959
[TBL] [Abstract][Full Text] [Related]
63. Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention.
Kim WU; Sreih A; Bucala R
Autoimmun Rev; 2009 Jan; 8(3):204-8. PubMed ID: 18722558
[TBL] [Abstract][Full Text] [Related]
64. Immune responses to DNA in normal and aberrant immunity.
Pisetsky DS
Immunol Res; 2000; 22(2-3):119-26. PubMed ID: 11339349
[TBL] [Abstract][Full Text] [Related]
65. DNA-dependent targeting of cell nuclei by a lupus autoantibody.
Weisbart RH; Chan G; Jordaan G; Noble PW; Liu Y; Glazer PM; Nishimura RN; Hansen JE
Sci Rep; 2015 Jul; 5():12022. PubMed ID: 26156563
[TBL] [Abstract][Full Text] [Related]
66. The anti-DNA antibody: origin and impact, dogmas and controversies.
Rekvig OP
Nat Rev Rheumatol; 2015 Sep; 11(9):530-40. PubMed ID: 26034836
[TBL] [Abstract][Full Text] [Related]
67. Immunological studies on DNA-lysine photoadduct.
Islam N; Ali R
Biochem Mol Biol Int; 1998 Jul; 45(3):453-64. PubMed ID: 9679646
[TBL] [Abstract][Full Text] [Related]
68. The role of in vitro expression systems in the investigation of antibodies to DNA.
Rahman A; Latchman DS; Isenberg DA
Semin Arthritis Rheum; 1998 Oct; 28(2):130-9. PubMed ID: 9806374
[TBL] [Abstract][Full Text] [Related]
69. Immune activation by bacterial DNA: a new genetic code.
Pisetsky DS
Immunity; 1996 Oct; 5(4):303-10. PubMed ID: 8885863
[No Abstract] [Full Text] [Related]
70. The central role of nucleic acids in the pathogenesis of systemic lupus erythematosus.
Pisetsky DS
F1000Res; 2019; 8():. PubMed ID: 31001416
[TBL] [Abstract][Full Text] [Related]
71. Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus.
Pisetsky DS
Arthritis Rheumatol; 2024 Apr; ():. PubMed ID: 38622070
[TBL] [Abstract][Full Text] [Related]
72. Molecular expression systems for anti-DNA antibodies--2.
Kumar S; Kalsi JK; Ravirajan CT; Latchman DS; Pearl LH; Isenberg DA
Lupus; 2002; 11(12):833-42. PubMed ID: 12529048
[TBL] [Abstract][Full Text] [Related]
73. The influence of susceptibility factors on the immune response to DNA.
Pisetsky DS
Environ Toxicol Pharmacol; 1997 Dec; 4(3-4):295-8. PubMed ID: 21781836
[TBL] [Abstract][Full Text] [Related]
74. Connective tissue diseases: HMGB1 helps elicit anti-dsDNA antibody production in SLE.
Cully M
Nat Rev Rheumatol; 2013 Jun; 9(6):321. PubMed ID: 23670137
[No Abstract] [Full Text] [Related]
75. T cells: A killer cytokine.
Bird L
Nat Rev Immunol; 2015 Aug; 15(8):466-7. PubMed ID: 26205580
[No Abstract] [Full Text] [Related]
76. Designing a type I interferon signaling phagosome.
Blander JM
Immunity; 2012 Dec; 37(6):947-9. PubMed ID: 23244713
[TBL] [Abstract][Full Text] [Related]
77. The origin and properties of extracellular DNA: from PAMP to DAMP.
Pisetsky DS
Clin Immunol; 2012 Jul; 144(1):32-40. PubMed ID: 22659033
[TBL] [Abstract][Full Text] [Related]
78. Standardization of anti-DNA antibody assays.
Pisetsky DS
Immunol Res; 2013 Jul; 56(2-3):420-4. PubMed ID: 23579774
[TBL] [Abstract][Full Text] [Related]
79. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.
Venner AA; Ibañez D; Gladman DD; Urowitz MB; MacKinnon A; Blasutig IM; Yip PM
Clin Biochem; 2013 Mar; 46(4-5):317-20. PubMed ID: 23246539
[TBL] [Abstract][Full Text] [Related]
80. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
